rs2075597

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001110792.2(MECP2):​c.413+22C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00688 in 1,162,678 control chromosomes in the GnomAD database, including 231 homozygotes. There are 2,465 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0091 ( 23 hom., 357 hem., cov: 24)
Exomes 𝑓: 0.0066 ( 208 hom. 2108 hem. )

Consequence

MECP2
NM_001110792.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: -0.426

Publications

4 publications found
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
MECP2 Gene-Disease associations (from GenCC):
  • chromosome Xq28 duplication syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • Rett syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet, G2P
  • severe neonatal-onset encephalopathy with microcephaly
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • syndromic X-linked intellectual disability Lubs type
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked intellectual disability-psychosis-macroorchidism syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant X-154032185-G-C is Benign according to our data. Variant chrX-154032185-G-C is described in ClinVar as Benign. ClinVar VariationId is 156054.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0948 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001110792.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
NM_001110792.2
MANE Select
c.413+22C>G
intron
N/ANP_001104262.1A0A140VKC4
MECP2
NM_004992.4
MANE Plus Clinical
c.377+22C>G
intron
N/ANP_004983.1D3YJ43
MECP2
NM_001316337.2
c.98+22C>G
intron
N/ANP_001303266.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
ENST00000453960.7
TSL:1 MANE Select
c.413+22C>G
intron
N/AENSP00000395535.2P51608-2
MECP2
ENST00000303391.11
TSL:1 MANE Plus Clinical
c.377+22C>G
intron
N/AENSP00000301948.6P51608-1
MECP2
ENST00000630151.3
TSL:5
c.377+22C>G
intron
N/AENSP00000486089.2P51608-1

Frequencies

GnomAD3 genomes
AF:
0.00911
AC:
1029
AN:
113000
Hom.:
24
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00315
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0442
Gnomad ASJ
AF:
0.000377
Gnomad EAS
AF:
0.103
Gnomad SAS
AF:
0.00648
Gnomad FIN
AF:
0.00191
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000769
Gnomad OTH
AF:
0.00920
GnomAD2 exomes
AF:
0.0215
AC:
3920
AN:
182491
AF XY:
0.0166
show subpopulations
Gnomad AFR exome
AF:
0.00237
Gnomad AMR exome
AF:
0.0809
Gnomad ASJ exome
AF:
0.000134
Gnomad EAS exome
AF:
0.104
Gnomad FIN exome
AF:
0.00157
Gnomad NFE exome
AF:
0.000727
Gnomad OTH exome
AF:
0.0184
GnomAD4 exome
AF:
0.00664
AC:
6971
AN:
1049624
Hom.:
208
Cov.:
26
AF XY:
0.00651
AC XY:
2108
AN XY:
323956
show subpopulations
African (AFR)
AF:
0.00133
AC:
34
AN:
25472
American (AMR)
AF:
0.0743
AC:
2609
AN:
35124
Ashkenazi Jewish (ASJ)
AF:
0.000314
AC:
6
AN:
19093
East Asian (EAS)
AF:
0.109
AC:
3285
AN:
30010
South Asian (SAS)
AF:
0.00468
AC:
248
AN:
52988
European-Finnish (FIN)
AF:
0.00138
AC:
56
AN:
40451
Middle Eastern (MID)
AF:
0.00201
AC:
8
AN:
3985
European-Non Finnish (NFE)
AF:
0.000495
AC:
395
AN:
798024
Other (OTH)
AF:
0.00742
AC:
330
AN:
44477
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
261
522
784
1045
1306
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00907
AC:
1025
AN:
113054
Hom.:
23
Cov.:
24
AF XY:
0.0101
AC XY:
357
AN XY:
35200
show subpopulations
African (AFR)
AF:
0.00314
AC:
98
AN:
31228
American (AMR)
AF:
0.0439
AC:
471
AN:
10737
Ashkenazi Jewish (ASJ)
AF:
0.000377
AC:
1
AN:
2656
East Asian (EAS)
AF:
0.103
AC:
371
AN:
3585
South Asian (SAS)
AF:
0.00614
AC:
17
AN:
2769
European-Finnish (FIN)
AF:
0.00191
AC:
12
AN:
6291
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.000769
AC:
41
AN:
53340
Other (OTH)
AF:
0.00909
AC:
14
AN:
1540
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
34
68
103
137
171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00532
Hom.:
31
Bravo
AF:
0.0145

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (4)
-
-
1
not specified (1)
-
-
1
Rett syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.080
DANN
Benign
0.63
PhyloP100
-0.43
PromoterAI
-0.0034
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2075597; hg19: chrX-153297636; COSMIC: COSV57655893; COSMIC: COSV57655893; API